Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04033146 · ClinicalTrials.gov registry record · NA

Optimizing Ankle Exoskeleton Assistance for Walking Across the Life Span

A NA study of Aging, sponsored by Georgia Institute of Technology.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04033146: Completed NA study of Aging, sponsored by Georgia Institute of Technology.

NCT04033146 is a NA study of Aging that has completed, run by Georgia Institute of Technology. The registered enrollment target is 16 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04033146, a NA study of Aging, has completed, sponsored by Georgia Institute of Technology.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The investigators seek to determine whether ankle exoskeletons can reduce metabolic energy expenditure during walking for users across the age-spectrum.

Primary Outcome

The rate of metabolic energy that participants expend during a short walking bout in each of the experimental conditions.

Conditions Studied

Interventions

  • DEVICE Ankle Exoskeleton Assistance

Study Locations (1)

Georgia

  • Physiology of Wearable Robotics Laboratory (Georgia Tech) - Atlanta

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2020-02-04
Est. Completion 2023-05-23
Phase NA
Georgia Institute of Technology

24 total trials

What the finished NCT04033146 record still lists

NCT04033146 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Ankle Exoskeleton Assistance is the first listed.

NCT04033146 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT04033146 about?

NCT04033146 is a clinical study titled "Optimizing Ankle Exoskeleton Assistance for Walking Across the Life Span". The investigators seek to determine whether ankle exoskeletons can reduce metabolic energy expenditure during walking for users across the age-spectrum.

What is the current status of trial NCT04033146?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2020-02-04. Estimated completion is 2023-05-23.

What conditions does trial NCT04033146 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT04033146?

The interventions under investigation include: Ankle Exoskeleton Assistance (DEVICE).

Who is sponsoring clinical trial NCT04033146?

This trial is sponsored by Georgia Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04033146 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04033146's enrollment target sits among peer trials

16 246th of 262 higher than 13 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04033146, the US trial registry maintained by the National Library of Medicine. NCT04033146 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.